SI1753871T1 - Protitelesa in sorodne molekule, ki se vežejo na psca proteine - Google Patents
Protitelesa in sorodne molekule, ki se vežejo na psca proteineInfo
- Publication number
- SI1753871T1 SI1753871T1 SI200532000T SI200532000T SI1753871T1 SI 1753871 T1 SI1753871 T1 SI 1753871T1 SI 200532000 T SI200532000 T SI 200532000T SI 200532000 T SI200532000 T SI 200532000T SI 1753871 T1 SI1753871 T1 SI 1753871T1
- Authority
- SI
- Slovenia
- Prior art keywords
- antibodies
- bind
- related molecules
- psca proteins
- psca
- Prior art date
Links
- 102000004169 proteins and genes Human genes 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/005—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies constructed by phage libraries
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/0002—General or multifunctional contrast agents, e.g. chelated agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
- C07K16/3069—Reproductive system, e.g. ovaria, uterus, testes, prostate
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/46—Hybrid immunoglobulins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/06—Preparation of peptides or proteins produced by the hydrolysis of a peptide bond, e.g. hydrolysate products
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
- C07K2317/734—Complement-dependent cytotoxicity [CDC]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/77—Internalization into the cell
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Animal Behavior & Ethology (AREA)
- Zoology (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cell Biology (AREA)
- Biomedical Technology (AREA)
- Pregnancy & Childbirth (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Reproductive Health (AREA)
- Gynecology & Obstetrics (AREA)
- Physics & Mathematics (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Virology (AREA)
- Mycology (AREA)
- Urology & Nephrology (AREA)
- Plant Pathology (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (9)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US2004/017231 WO2005014780A2 (fr) | 2003-05-30 | 2004-05-28 | Variants de l'antigene de cellules souches de la prostate (psca) et utilisations subsequentes de ceux-ci |
US10/857,484 US7622564B2 (en) | 2003-05-30 | 2004-05-28 | Prostate stem cell antigen (PSCA) variants and subsequences thereof |
US61638104P | 2004-10-05 | 2004-10-05 | |
US61788104P | 2004-10-12 | 2004-10-12 | |
US62131004P | 2004-10-21 | 2004-10-21 | |
US63307704P | 2004-12-02 | 2004-12-02 | |
US67200005P | 2005-04-14 | 2005-04-14 | |
EP05752076.9A EP1753871B1 (fr) | 2004-05-28 | 2005-05-17 | Anticorps et molecules apparentees qui se lient aux proteines d'antigene des cellules souches de prostate (proteines de psca) |
PCT/US2005/017412 WO2005118864A2 (fr) | 2004-05-28 | 2005-05-17 | Anticorps et molecules apparentees qui se lient aux proteines d'antigene des cellules souches de prostate (proteines de psca) |
Publications (1)
Publication Number | Publication Date |
---|---|
SI1753871T1 true SI1753871T1 (sl) | 2016-01-29 |
Family
ID=44210117
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SI200532000T SI1753871T1 (sl) | 2004-05-28 | 2005-05-17 | Protitelesa in sorodne molekule, ki se vežejo na psca proteine |
Country Status (6)
Country | Link |
---|---|
KR (2) | KR101282396B1 (fr) |
CN (1) | CN102344493B (fr) |
BR (2) | BRPI0511624B1 (fr) |
IL (1) | IL214210A (fr) |
NO (1) | NO341404B1 (fr) |
SI (1) | SI1753871T1 (fr) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3851856A3 (fr) | 2007-03-27 | 2021-11-03 | Immunovia AB | Procédé, réseau et son utilisation |
KR102355959B1 (ko) * | 2012-08-23 | 2022-01-27 | 어젠시스 인코포레이티드 | 158p1d7 단백질에 결합하는 항체 약물 컨쥬게이트(adc) |
KR20230156146A (ko) * | 2012-12-13 | 2023-11-13 | 더 트러스티스 오브 더 유니버시티 오브 펜실베니아 | Dna 항체 작제물 및 그 이용 방법 |
WO2015089492A2 (fr) | 2013-12-13 | 2015-06-18 | The Trustees Of The University Of Pennsylvania | Constructions d'anticorps d'adn et procédé d'utilisation |
GB201319878D0 (en) * | 2013-11-11 | 2013-12-25 | Immunovia Ab | Method, Array and use thereof |
AU2015355126B9 (en) | 2014-12-01 | 2020-03-26 | Inovio Pharmaceuticals, Inc. | DNA antibody constructs and method of using same |
GB202010970D0 (en) | 2020-07-16 | 2020-09-02 | Immunovia Ab | Methods, arrays and uses thereof |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6258939B1 (en) * | 1997-03-10 | 2001-07-10 | The Regents Of The University Of California | PSCA antibodies and hybridomas producing them |
AU739407C (en) * | 1997-03-10 | 2002-08-08 | Regents Of The University Of California, The | PSCA: prostate stem cell antigen |
US6541212B2 (en) * | 1997-03-10 | 2003-04-01 | The Regents Of The University Of California | Methods for detecting prostate stem cell antigen protein |
NZ518477A (en) * | 1999-10-29 | 2004-10-29 | Genentech Inc | Isolated anti-prostate stem cell antigen (PSCA) antibodies that internalise upon binding to PSCA on a mammalian cell, including a PSCA-expressing tumour cell, in vivo |
-
2005
- 2005-05-17 BR BRPI0511624-4A patent/BRPI0511624B1/pt active IP Right Grant
- 2005-05-17 BR BR122018073034-0A patent/BR122018073034B1/pt active IP Right Grant
- 2005-05-17 KR KR1020117010832A patent/KR101282396B1/ko active IP Right Grant
- 2005-05-17 SI SI200532000T patent/SI1753871T1/sl unknown
- 2005-05-17 CN CN201110118165.5A patent/CN102344493B/zh active Active
-
2006
- 2006-12-28 KR KR1020067027763A patent/KR101215611B1/ko active IP Right Grant
-
2011
- 2011-04-29 NO NO20110647A patent/NO341404B1/no unknown
- 2011-07-20 IL IL214210A patent/IL214210A/en active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
BRPI0511624A (pt) | 2008-01-02 |
CN102344493B (zh) | 2014-09-03 |
KR101215611B1 (ko) | 2012-12-28 |
CN102344493A (zh) | 2012-02-08 |
KR101282396B1 (ko) | 2013-07-04 |
BR122018073034B8 (fr) | 2022-10-11 |
IL214210A0 (en) | 2011-08-31 |
NO341404B1 (no) | 2017-10-30 |
NO20110647L (no) | 2006-12-19 |
BRPI0511624B1 (pt) | 2022-02-08 |
BR122018073034B1 (pt) | 2021-10-13 |
IL214210A (en) | 2013-01-31 |
KR20110056564A (ko) | 2011-05-30 |
KR20070047251A (ko) | 2007-05-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1253391A1 (zh) | 與161p2f10b蛋白結合的抗體和相關分子 | |
HK1102012A1 (en) | Antibodies and molecules derived therefrom that bind to steap-1 proteins | |
IL179332A0 (en) | Antibodies and related molecules that bind to psca proteins | |
HRP20130649T1 (hr) | Protutijela i povezane molekule koje se vežu za 24p4c12 proteine | |
EP1868647A4 (fr) | Anticorps se liant à ov064 et leurs méthodes d'utilisation | |
ZA200709630B (en) | Antigen binding molecules having modified Fc regions and altered binding to Fc receptors | |
IL179891A (en) | Antibodies and immune couplings associated with CD44e and their methods and uses | |
HK1173158A1 (en) | Antibodies directed to her-3 and uses thereof her-3 | |
EP1610818A4 (fr) | Anticorps modifies diriges contre un antigene membranaire specifique de la prostate | |
EP1846032A4 (fr) | Luca2 et anticorps s'y liant | |
HK1107402A1 (en) | Kid31 and antibodies that bind thereto kid31 | |
SI1753871T1 (sl) | Protitelesa in sorodne molekule, ki se vežejo na psca proteine | |
ZA200609894B (en) | Antibodies and elated molecules that bind to PSCA proteins | |
ZA200709303B (en) | Antibodies and related molecules that bind to 161P2F210B proteins | |
WO2006116319A3 (fr) | Reactifs se liant au ccx-ckr2 | |
EP1919951A4 (fr) | Anticorps anti-tnf-alpha et procedes d'utilisation | |
ZA200609068B (en) | Antibodies and molecules derived therefrom that bind to STEAP-1 proteins | |
SI2185574T1 (sl) | Protitelesa in sorodne molekule, ki se veĹľejo k 24P4C12 proteinom | |
GB0506210D0 (en) | Methods for identifying proteins and the ligands that bind to them |